SlideShare uma empresa Scribd logo
1 de 12
Safety Pharmacology for  Oncology Pharmaceuticals at CDER John K. Leighton Associate Director for Pharmacology CDER/OND/OODP
Disclaimer ,[object Object]
Definitions ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Oncology Drugs ,[object Object],[object Object],[object Object]
Oncology Drugs ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Oncology Biologics ICH S6 ,[object Object]
ICH S9 Draft Proposal ,[object Object]
Current Status Safety Pharmacology CDER OODP ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Case Studies ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object]
Questions ,[object Object],[object Object],[object Object],[object Object]
Questions ,[object Object],[object Object],[object Object],[object Object]

Mais conteúdo relacionado

Mais procurados

Safety pharmacology by tasnim
Safety pharmacology by tasnimSafety pharmacology by tasnim
Safety pharmacology by tasnimTasnim Taher
 
Introduction to clinical trial
Introduction to clinical trialIntroduction to clinical trial
Introduction to clinical trialABUBAKRANSARI2
 
Pharmacological Approach to Drug Discovery
Pharmacological Approach to Drug DiscoveryPharmacological Approach to Drug Discovery
Pharmacological Approach to Drug DiscoverySuhas Reddy C
 
Pharmacological Approach for drug development
Pharmacological Approach for drug developmentPharmacological Approach for drug development
Pharmacological Approach for drug developmentDr Duggirala Mahendra
 
Approaches of drug discovery
Approaches of drug discoveryApproaches of drug discovery
Approaches of drug discoveryGaurav Sharma
 
David Neasham Practical Use Pharmacoepi Drug Dev
David Neasham Practical Use Pharmacoepi Drug DevDavid Neasham Practical Use Pharmacoepi Drug Dev
David Neasham Practical Use Pharmacoepi Drug Devguest41e570
 
Safety pharmacology studies
Safety pharmacology studies Safety pharmacology studies
Safety pharmacology studies Santosh Sai
 
Pharmacoepidemiology
PharmacoepidemiologyPharmacoepidemiology
PharmacoepidemiologyDivjyot Kaur
 
Pharmacoepidemiology
PharmacoepidemiologyPharmacoepidemiology
PharmacoepidemiologyStanley Palma
 
Scope of Pharmacy and Clinical Research
Scope of Pharmacy and Clinical ResearchScope of Pharmacy and Clinical Research
Scope of Pharmacy and Clinical ResearchMansi Pawar
 
introduction to Pharmacoepidemiology
introduction to Pharmacoepidemiology introduction to Pharmacoepidemiology
introduction to Pharmacoepidemiology aiswarya thomas
 
Pharmacoepidemiology
PharmacoepidemiologyPharmacoepidemiology
PharmacoepidemiologyAsma Ashraf
 
Definition, historical landmarks, scope of pharmacology
Definition, historical landmarks, scope of pharmacologyDefinition, historical landmarks, scope of pharmacology
Definition, historical landmarks, scope of pharmacologyRupali Patil
 
Safety pharmacology
Safety pharmacologySafety pharmacology
Safety pharmacologySourabhAtak
 
Pharmacoepidemiology (2)
Pharmacoepidemiology (2)Pharmacoepidemiology (2)
Pharmacoepidemiology (2)Ahmad Ali
 
Pharmacoepidemiology
PharmacoepidemiologyPharmacoepidemiology
PharmacoepidemiologyVibha Manu
 

Mais procurados (20)

Safety pharmacology by tasnim
Safety pharmacology by tasnimSafety pharmacology by tasnim
Safety pharmacology by tasnim
 
Introduction to clinical trial
Introduction to clinical trialIntroduction to clinical trial
Introduction to clinical trial
 
Pharmacoepidemiology
Pharmacoepidemiology Pharmacoepidemiology
Pharmacoepidemiology
 
Safety pharmacology
Safety pharmacologySafety pharmacology
Safety pharmacology
 
Pharmacological Approach to Drug Discovery
Pharmacological Approach to Drug DiscoveryPharmacological Approach to Drug Discovery
Pharmacological Approach to Drug Discovery
 
Safety pharmacology
Safety pharmacologySafety pharmacology
Safety pharmacology
 
Pharmacological Approach for drug development
Pharmacological Approach for drug developmentPharmacological Approach for drug development
Pharmacological Approach for drug development
 
Approaches of drug discovery
Approaches of drug discoveryApproaches of drug discovery
Approaches of drug discovery
 
David Neasham Practical Use Pharmacoepi Drug Dev
David Neasham Practical Use Pharmacoepi Drug DevDavid Neasham Practical Use Pharmacoepi Drug Dev
David Neasham Practical Use Pharmacoepi Drug Dev
 
Safety pharmacology studies
Safety pharmacology studies Safety pharmacology studies
Safety pharmacology studies
 
Pharmacoepidemiology
PharmacoepidemiologyPharmacoepidemiology
Pharmacoepidemiology
 
Pharmacoepidemiology
PharmacoepidemiologyPharmacoepidemiology
Pharmacoepidemiology
 
Scope of Pharmacy and Clinical Research
Scope of Pharmacy and Clinical ResearchScope of Pharmacy and Clinical Research
Scope of Pharmacy and Clinical Research
 
introduction to Pharmacoepidemiology
introduction to Pharmacoepidemiology introduction to Pharmacoepidemiology
introduction to Pharmacoepidemiology
 
Pharmacoepidemiology
PharmacoepidemiologyPharmacoepidemiology
Pharmacoepidemiology
 
Definition, historical landmarks, scope of pharmacology
Definition, historical landmarks, scope of pharmacologyDefinition, historical landmarks, scope of pharmacology
Definition, historical landmarks, scope of pharmacology
 
Safety pharmacology
Safety pharmacologySafety pharmacology
Safety pharmacology
 
Pharmacology
PharmacologyPharmacology
Pharmacology
 
Pharmacoepidemiology (2)
Pharmacoepidemiology (2)Pharmacoepidemiology (2)
Pharmacoepidemiology (2)
 
Pharmacoepidemiology
PharmacoepidemiologyPharmacoepidemiology
Pharmacoepidemiology
 

Semelhante a Provappt

Safety pharmacology studies in drug development
Safety pharmacology studies in drug developmentSafety pharmacology studies in drug development
Safety pharmacology studies in drug developmentAnkita
 
Safety pharmacology
Safety pharmacologySafety pharmacology
Safety pharmacologyAanchal46
 
Safety pharmacology and clinical trials
Safety pharmacology and clinical trialsSafety pharmacology and clinical trials
Safety pharmacology and clinical trialsAkash Agnihotri
 
various approaches to drug discovery
various approaches to drug discoveryvarious approaches to drug discovery
various approaches to drug discoveryaiswarya thomas
 
Regulatory guidelines for conducting toxicity studies by ich
Regulatory guidelines for conducting toxicity studies by ichRegulatory guidelines for conducting toxicity studies by ich
Regulatory guidelines for conducting toxicity studies by ichAnimatedWorld
 
Safety s7 a-seminar-ppt-pptx
Safety s7 a-seminar-ppt-pptxSafety s7 a-seminar-ppt-pptx
Safety s7 a-seminar-ppt-pptxSanthanakumar21
 
Investigators brochure
Investigators brochureInvestigators brochure
Investigators brochureSohil Shah
 
Current Pharmacology & Toxicology Guidlines For Pharmaceutical Industry
Current Pharmacology & Toxicology Guidlines For Pharmaceutical IndustryCurrent Pharmacology & Toxicology Guidlines For Pharmaceutical Industry
Current Pharmacology & Toxicology Guidlines For Pharmaceutical IndustryProf. Dr. Basavaraj Nanjwade
 
introductiontopharmacoepidemiology-230613144442-c713d639.pdf
introductiontopharmacoepidemiology-230613144442-c713d639.pdfintroductiontopharmacoepidemiology-230613144442-c713d639.pdf
introductiontopharmacoepidemiology-230613144442-c713d639.pdfOgunsina1
 
INTRODUCTION TO PHARMACOEPIDEMIOLOGY.pptx
INTRODUCTION TO PHARMACOEPIDEMIOLOGY.pptxINTRODUCTION TO PHARMACOEPIDEMIOLOGY.pptx
INTRODUCTION TO PHARMACOEPIDEMIOLOGY.pptxAmeena Kadar
 
IMMUNOTOXICITY STUDIES FOR HUMAN PHARMACEUTICALS.pptx
IMMUNOTOXICITY STUDIES FOR HUMAN PHARMACEUTICALS.pptxIMMUNOTOXICITY STUDIES FOR HUMAN PHARMACEUTICALS.pptx
IMMUNOTOXICITY STUDIES FOR HUMAN PHARMACEUTICALS.pptxHafsaKhan950550
 
Safety guidelines- S3A and S3B
Safety guidelines- S3A and S3BSafety guidelines- S3A and S3B
Safety guidelines- S3A and S3Banshagrawal2121
 
Extrapolation of in vitro data to preclinical and.pptx
Extrapolation of in vitro data to preclinical and.pptxExtrapolation of in vitro data to preclinical and.pptx
Extrapolation of in vitro data to preclinical and.pptxARSHIKHANAM4
 

Semelhante a Provappt (20)

Safety pharmacology
Safety pharmacologySafety pharmacology
Safety pharmacology
 
Safety pharmacology studies in drug development
Safety pharmacology studies in drug developmentSafety pharmacology studies in drug development
Safety pharmacology studies in drug development
 
Safety pharmacology
Safety pharmacologySafety pharmacology
Safety pharmacology
 
Toxicology Screening Models.pptx
Toxicology Screening Models.pptxToxicology Screening Models.pptx
Toxicology Screening Models.pptx
 
ICH Safety Guidelines
ICH Safety GuidelinesICH Safety Guidelines
ICH Safety Guidelines
 
Safety pharmacology and clinical trials
Safety pharmacology and clinical trialsSafety pharmacology and clinical trials
Safety pharmacology and clinical trials
 
various approaches to drug discovery
various approaches to drug discoveryvarious approaches to drug discovery
various approaches to drug discovery
 
Safety Pharmacology Studies ICH guideline S7A
Safety Pharmacology Studies ICH guideline S7ASafety Pharmacology Studies ICH guideline S7A
Safety Pharmacology Studies ICH guideline S7A
 
Regulatory guidelines for conducting toxicity studies by ich
Regulatory guidelines for conducting toxicity studies by ichRegulatory guidelines for conducting toxicity studies by ich
Regulatory guidelines for conducting toxicity studies by ich
 
Safety s7 a-seminar-ppt-pptx
Safety s7 a-seminar-ppt-pptxSafety s7 a-seminar-ppt-pptx
Safety s7 a-seminar-ppt-pptx
 
My ppt.
My ppt.My ppt.
My ppt.
 
Investigators brochure
Investigators brochureInvestigators brochure
Investigators brochure
 
Current Pharmacology & Toxicology Guidlines For Pharmaceutical Industry
Current Pharmacology & Toxicology Guidlines For Pharmaceutical IndustryCurrent Pharmacology & Toxicology Guidlines For Pharmaceutical Industry
Current Pharmacology & Toxicology Guidlines For Pharmaceutical Industry
 
Pre Clinical Studies
Pre Clinical StudiesPre Clinical Studies
Pre Clinical Studies
 
introductiontopharmacoepidemiology-230613144442-c713d639.pdf
introductiontopharmacoepidemiology-230613144442-c713d639.pdfintroductiontopharmacoepidemiology-230613144442-c713d639.pdf
introductiontopharmacoepidemiology-230613144442-c713d639.pdf
 
INTRODUCTION TO PHARMACOEPIDEMIOLOGY.pptx
INTRODUCTION TO PHARMACOEPIDEMIOLOGY.pptxINTRODUCTION TO PHARMACOEPIDEMIOLOGY.pptx
INTRODUCTION TO PHARMACOEPIDEMIOLOGY.pptx
 
IMMUNOTOXICITY STUDIES FOR HUMAN PHARMACEUTICALS.pptx
IMMUNOTOXICITY STUDIES FOR HUMAN PHARMACEUTICALS.pptxIMMUNOTOXICITY STUDIES FOR HUMAN PHARMACEUTICALS.pptx
IMMUNOTOXICITY STUDIES FOR HUMAN PHARMACEUTICALS.pptx
 
Clinical Trials - An Introduction
Clinical Trials - An IntroductionClinical Trials - An Introduction
Clinical Trials - An Introduction
 
Safety guidelines- S3A and S3B
Safety guidelines- S3A and S3BSafety guidelines- S3A and S3B
Safety guidelines- S3A and S3B
 
Extrapolation of in vitro data to preclinical and.pptx
Extrapolation of in vitro data to preclinical and.pptxExtrapolation of in vitro data to preclinical and.pptx
Extrapolation of in vitro data to preclinical and.pptx
 

Provappt

  • 1. Safety Pharmacology for Oncology Pharmaceuticals at CDER John K. Leighton Associate Director for Pharmacology CDER/OND/OODP
  • 2.
  • 3.
  • 4.
  • 5.
  • 6.
  • 7.
  • 8.
  • 9.
  • 10.
  • 11.
  • 12.